PATIENTS CARE ABOUT CURES, NOT CONFLICT OF INTEREST
More than a third of doctors who sit on review boards overseeing the integrity of clinical trials do not bother to disclose a financial stake in the outcome, a study in the New England Journal of Medicine has shown. However this does not shock cancer patients. In the same journal another study found that 80% were “not worried at all” if a doctor profited from a tested drug. In fact, most patients said that they opposed bans on such relationships. The author of the study said that this was quite understandable since participants in clinical trials “are very vulnerable, have a serious problem and want someone to care for it.”
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
BioEdge has closed its doors
After 23 years, BioEdge ceased published in May 2024. Not that there isn't lots to report on and talk about,...
How liberal are American bioethicists?
There is growing acknowledgement of the fact that the backgrounds, ideas, and politics of American academics are out of step...
Doctors can be socialized to cooperate in morally despicable evil, says bioethicist
Bioethicist Carl Elliott seems to relish stirring up fellow bioethicists and the medical profession. In his latest book, The Occasional Human...
3 sperm donors from same family in Quebec have sired 600 children
Three men in Quebec from the same family have fathered more than 600 children by offering free sperm on the...
American IVF clinics are happily offering sex selection
The United States is one of the few countries where IVF sex selection is legal – and it is a...
Owner of castration website in UK found guilty of grievous bodily harm
“Enhancement” normally connotes adding powers beyond normal human functioning. However, there are dark kinds of enhancement which remove them. A...